PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
15-Jun-2022 Diabetic Shoes Market is expected to grow at 6.4% CAGR during the forecast period of 2022-2032 MARKITWIRED
15-Jun-2022 SHIONOGI SIGNS AGREEMENT WITH NHS ENGLAND TO BEGIN AN INNOVATIVE SUBSCRIPTION PAYMENT MODEL FOR REIMBURSEMENT OF ITS ANTIBIOTIC, FETCROJA®▼ (CEFIDEROCOL) Shionogi
15-Jun-2022 CatSci Receive Significant Investment from Keensight Capital CatSci Ltd
15-Jun-2022 Orion Acquires Inovet’s Animal Health Business Orion Corporation
15-Jun-2022 ProteoNic Announces Licensing of its 2G UNic™ Technology Platform for Production of Biologics to GenScript ProBio ProteoNic BV
15-Jun-2022 Aqilion resolves on issue in kind AQILION AB
15-Jun-2022 Almac Group records highest ever revenue, profit and employee numbers as $250 million global expansion plans announced Almac Group
15-Jun-2022 Immersive diabetes experience launched to tackle poor understanding of disease burden among pharma and healthcare The Method
15-Jun-2022 Patient Transportation Market to Grow at 5.9% through 2032 As Demand for Assistive Equipment Continues to Grow   MARKITWIRED
15-Jun-2022 Obtaining High-yield and Bioactive B. subtilis Bioproducts with Creative Biogene’s Cultivation Support Creative Biogene
15-Jun-2022 ePharmacy Market is to Boom at a CAGR of 16.5% by 2032 and to reach US$ 329.83 billion by 2032 MARKITWIRED
15-Jun-2022 BioWin, CETIC and essenscia wallonie launch BioMan initiative to accelerate digitization of bioprocesses in Wallonia Andrew Lloyd Associates
15-Jun-2022 Innovent and Etana Jointly Announce the Approval of Bevagen by the Indonesian Food and Drugs Authority (BPOM) Legend Capital
15-Jun-2022 ProteoNic Announces Licensing of its 2G UNic™ Technology Platform for Production of Biologics to GenScript ProBio B3C newswire
15-Jun-2022 Europe Radiotherapy Patient Positioning Market is set to display a substantial growth at 4.1% CAGR from 2022 to 2032 MARKITWIRED
15-Jun-2022 Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports Q1 2022 Financial Results and Highlights Operational Progress (news with additional features) Vivoryon Therapeutics N.V.
14-Jun-2022 MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210 MorphoSys AG
14-Jun-2022 Novotech's APAC and USA Leadership Teams at BIO 2022 Novotech Health Holdings Pte Ltd
14-Jun-2022 ValenzaBio Engages ProBioGen For a Second Service Project ValenzaBio
14-Jun-2022 mdgroup appoints LaQuinta Jernigan as Chief Operating Officer mdgroup